slotkoers
Korea S.E.
00:00:00 24-06-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
531
KRW
|
-6,18%
|
|
-7,97%
|
-31,40%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
---|
Marktkapitalisatie
1 |
373.324
|
448.866
|
269.557
|
187.565
|
Bedrijfswaarde
1 |
362.576
|
419.679
|
251.266
|
181.370
|
K/w-verhouding
|
-7,92
x
|
-18,8
x
|
-10,8
x
|
-7,66
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
219
x
|
157
x
|
316
x
|
81,7
x
|
Bedrijfswaarde/omzet
|
213
x
|
147
x
|
295
x
|
79
x
|
Bedrijfswaarde/EBITDA
|
-19,4
x
|
-20,5
x
|
-11,4
x
|
-8,5
x
|
Bedrijfswaarde/FCF
|
-9,84
x
|
-24
x
|
-18,9
x
|
-24,8
x
|
FCF Yield
|
-10,2%
|
-4,18%
|
-5,28%
|
-4,03%
|
Price to Book
|
19,4
x
|
10,8
x
|
9,33
x
|
19,6
x
|
Aantal aandelen (in duizenden)
|
23.829
|
24.351
|
29.332
|
30.799
|
Referentieprijs
2 |
15.667
|
18.433
|
9.190
|
6.090
|
Datum van publicatie
|
17/03/20
|
10/03/21
|
14/03/22
|
20/03/23
|
Fiscaal tijdperk: december |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Omzet
1 |
111,9
|
488,3
|
1.705
|
2.861
|
851,8
|
2.296
|
EBITDA
1 |
-9.271
|
-16.164
|
-18.703
|
-20.482
|
-22.116
|
-21.343
|
Bedrijfsresultaat (EBIT)
1 |
-11.715
|
-18.542
|
-21.666
|
-23.698
|
-25.133
|
-24.130
|
Operationele Marge
|
-10.466,39%
|
-3.797,53%
|
-1.270,51%
|
-828,4%
|
-2.950,71%
|
-1.050,94%
|
Resultaat voor belastingen (EBT)
1 |
-15.481
|
-23.697
|
-46.427
|
-24.579
|
-25.724
|
-24.752
|
Nettowinst (verlies)
1 |
-13.195
|
-27.049
|
-45.640
|
-24.183
|
-25.135
|
-24.168
|
Nettomarge
|
-11.788,56%
|
-5.540,01%
|
-2.676,37%
|
-845,35%
|
-2.950,84%
|
-1.052,59%
|
WPA
2 |
-764,7
|
-1.433
|
-1.978
|
-980,0
|
-851,0
|
-795,0
|
Free Cash Flow
1 |
-10.329
|
-40.228
|
-36.863
|
-17.522
|
-13.264
|
-7.302
|
FCF-marge
|
-9.228,55%
|
-8.239,14%
|
-2.161,67%
|
-612,5%
|
-1.557,19%
|
-318,05%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
1/04/18
|
3/04/19
|
17/03/20
|
10/03/21
|
14/03/22
|
20/03/23
|
Fiscaal tijdperk: december |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Nettoschuldpositie
1 |
7.255
|
19.910
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
-
|
-
|
10.748
|
29.187
|
18.291
|
6.195
|
Hefboom (schuld/ebitda)
|
-0,7826
x
|
-1,232
x
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-10.329
|
-40.228
|
-36.863
|
-17.522
|
-13.264
|
-7.302
|
ROE (netto-inkomsten/eigen vermogen)
|
-89,1%
|
72,9%
|
585%
|
-79,3%
|
-70,1%
|
-126%
|
ROA (netto-inkomsten/totale activa)
|
-15,3%
|
-25,1%
|
-30,4%
|
-24,1%
|
-27,5%
|
-42,5%
|
Totale activa
1 |
86.002
|
107.596
|
150.315
|
100.379
|
91.480
|
56.894
|
Nettoactief per aandeel
2 |
632,0
|
-1.554
|
809,0
|
1.710
|
985,0
|
310,0
|
Cashflow per aandeel
2 |
2.199
|
213,0
|
1.258
|
1.997
|
293,0
|
425,0
|
Capex
1 |
1.173
|
2.276
|
784
|
2.156
|
1.124
|
157
|
Capex/omzet
|
1.048,2%
|
466,05%
|
45,98%
|
75,38%
|
132,01%
|
6,82%
|
Datum van publicatie
|
1/04/18
|
3/04/19
|
17/03/20
|
10/03/21
|
14/03/22
|
20/03/23
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -31,40% | 13,34 mln. | | +16,45% | 123 mld. | | +21,96% | 115 mld. | | +23,73% | 25,85 mld. | | -20,05% | 20,9 mld. | | -16,28% | 16,77 mld. | | -16,52% | 16,52 mld. | | -44,35% | 15,56 mld. | | +63,91% | 15,49 mld. | | +2,52% | 13,45 mld. |
Biotherapeutische geneesmiddelen
|